{"id":"W2795076534","doi":"10.1016/j.blre.2018.03.006","title":"Time to repeal and replace response criteria for acute myeloid leukemia?","year":2018,"lang":"en","type":"review","venue":"Blood Reviews","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Bristol-Myers Squibb; Agios Pharmaceuticals; Celgene; Daiichi-Sankyo; Pfizer; Amgen","keywords":"Medicine; Clinical trial; Intensive care medicine; Minimal residual disease; Myeloid leukemia; Oncology; Disease; Immunology; Internal medicine; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01106486,0.0007735957,0.002363352,0.002122114,0.0004328778,0.002174887,0.002171471,0.003111036,0.002910351],"category_scores_gemma":[0.0180455,0.0004515794,0.001303485,0.002282878,0.002010088,0.005800874,0.001137597,0.007557137,0.002112769],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00197052,"about_ca_system_score_gemma":0.004835319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003786605,"about_ca_topic_score_gemma":0.005117042,"domain_scores_codex":[0.9969951,0.001201987,0.0006897337,0.0002848159,0.0007121774,0.0001162683],"domain_scores_gemma":[0.9891109,0.006931285,0.0009369763,0.0002901336,0.002458949,0.0002718922],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001186042,0.00003775772,0.0002036631,0.01868164,0.0001211001,0.00009274825,0.0002210737,0.0001835932,0.000349987,0.01477835,0.09134909,0.8738624],"study_design_scores_gemma":[0.00003737997,0.00006710939,0.0005448255,0.01552786,0.0001086483,0.0004200983,0.0002109254,0.00005252032,0.00009704212,0.005247401,0.9776577,0.00002835383],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005299936,0.9889526,0.0001761897,0.008798686,0.001603964,0.000008365572,0.00001734506,0.00001004862,0.0003798262],"genre_scores_gemma":[0.001173719,0.9853839,0.001043914,0.01013928,0.001613847,0.00002666606,0.00005548649,0.00001237865,0.0005507764],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01106486,"threshold_uncertainty_score":0.05851728,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07172630987163685,"score_gpt":0.4155518578424391,"score_spread":0.3438255479708022,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}